The use of monosodium glutamate (MSG) as a flavor enhancer spans more than 100 y and there are many studies indicating the safety of general use of MSG. Recently, however, Collison et al. (2010) reported a two-generation study with a low dose of MSG that caused abdominal obesity, insulin resistance and dyslipidemia in mice. Due to public health concerns over metabolic syndrome, their report merits careful analysis. The present study attempted to repeat the Collison et al. findings. Groups of male or female C57BL/6J mice were fed a control diet or one supplemented with high-fructose corn syrup (HFCS) at a level of 20%. Drinking water control was provided or treatment groups were given 0.064% MSG solution (w/v). Diets and MSG administration continued throughout mating and during gestation and lactation periods. To further investigate the effects of ingestion of MSG, the offspring were continued on the same dosing conditions until they reached 32 wk of age. MSG administration in mice fed a normal or a HFCS diet throughout gestation and for 32 wk after birth, did not affect growth, girth size, abdominal fat weight or body composition. This study reports that MSG did not trigger insulin resistance, dyslipidemia or hepatic steatosis, regardless of the diet, not reproducing the results of the above-mentioned study (Collison et al., 2010) .
Since the discovery by Dr. Ikeda in 1908 that glutamate and/or its salts are the source of the savory taste of traditional Japanese soup, monosodium glutamate (MSG), the sodium salt of glutamate, has been commonly used around the world in a wide range of foods to create a smooth, rich, and full-bodied flavour (1) . In recent years, it has been recognized that the taste of glutamate, i.e., "umami," is one of the five basic tastes, along with sweet, bitter, salt, and sour (2) . Glutamate receptors have been found on the taste cells of gustatory buds (3) . Since glutamate is one of the major amino acid constituents of proteins, "umami" taste is considered to be a nutritional signal of protein ingestion (4) .
Mammals have a long history of free (non-protein) and protein-bound glutamate intake. In the case of humans, the daily intake of free glutamate in various forms, including savory sources, cheese, anchovy, vegetables, condiments and MSG, is more than 1 g and average daily intake of total glutamate including the protein-bound form is 10 g (5) . Use of MSG as a commercial seasoning spans 100 y, while the history of utilizing free glutamate can be traced back thousands of years (6) .
Most of ingested glutamate is metabolized in the first digestive pass, i.e. in the gut to CO 2, lactate, alanine and other metabolites (7) (8) (9) . Thus, ingestion of food-originating glutamate does not change the plasma concentration of glutamate despite its high content in some foods (10, 11) , probably due to an efficient homeostatic control that evolved for this critical taste signal molecule. Indeed, JECFA and governments including the United States and European Community have evaluated the safety of free glutamate and its salts based on physiological, etiological and toxicological data on glutamate and its salts (12) . However, Collison et al. (13) recently reported that MSG administration to mice in drinking water caused abdominal fat deposition, fatty liver, insulin resistance and dyslipidemia in the second generation of treated mice despite the dose of MSG being low compared to the dietary intake level of glutamate in food. While the results (13) did not agree with previous studies on the metabolic safety of free glutamates including MSG (7-10, 14, 15) , they were of interest due to increased reports of metabolic syndrome world-wide (16, 17) . Therefore, the present research project was aimed at testing the reproducibility of the initial report (13) on mice fed either normal or high fructose corn syrup (HFCS) diets and given MSG in their drinking water. We construed that Collison et al. (13) did not use objective parameters to access fat deposition, so we measured the
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actual weight of abdominal fat and body composition using the D2O dilution method. Other methods were as reported by the original authors (13) .
MATeRIALS AND MeThODS
Test substance. l-Glutamic acid monosodium salt monohydrate, CAS Number 6106-04-3, MSG (Ajinomoto Co., Inc., Tokyo, Japan) was supplied as a white crystalline powder and stored at room temperature. The quality of the test substance met the standards of the Food Chemicals Codex (2010) (purity 98.5-101.5%, inorganic impurity0.2%).
Animals, diets and experimental design. The study received prior approval from Ajinomoto's Institutional Animal Care and Use Committee. Male and female C57BL/6J 6-wk-old mice were purchased from Charles River Laboratories Japan (Atsugi, Japan) and were maintained in controlled conditions at 2361˚C and 60610% humidity with a 12 h light (0700 to 1900) and 12 h dark cycle. After 1 wk of acclimation in our facility, the mice were divided into 2 groups of each sex (n520 per group) and were given either tap water or 0.064% of MSG solution (w/v) as drinking water. Animals were housed in plastic cages (5 animals per cage) and had free access to these drinking waters. The mice were fed ad libitum with a standard diet (LabDiet 5001; PMI, St. Louis, MO) in study 1 and with a high fructose corn syrup (HFCS) diet (5C4K; TestDiet Purina, Richmond, IN) in study 2. The HFCS diet contained 20% HFCS on the basis of the standard diet. Three weeks later, 20 couples of male and female mice were mated. Pregnant females were maintained individually and their pups were weaned 3 wk after delivery. Twenty male first-generation (F 1) mice were selected randomly in each group and were maintained with the same diets and the same drinking water for an additional 29 wk.
The abdominal width of F1 mice at 6 and 32 wk old were measured using a micrometer caliper as an indicator of abdominal girth. The body weight of each animal and food and water consumptions of each cage (5 mice/ cage) were measured at 28-30 wk of age. Blood samples were collected from the tail vein at 32 wk after 6 h of fasting (7:00 am to 1:00 pm) for measurements of blood glucose and plasma insulin. Three days after the blood collection, animals were intraperitoneally injected with 100 mL of 5% D2O saline (5 mg D2O/head) for the measurement of total fat mass as described later and were fasted for 4 h (9:00 am to 1:00 pm). They were then sacrificed under isoflurane anesthesia to collect plasma samples and to harvest epididymal, perirenal and mesenteric fat pads and liver. Inguinal fat pads and the median lobe of the liver were fixed in neutral buffered formalin. The other parts of the liver and plasma samples were stored at 280˚C pending-biochemical analysis.
Measurements of total body fat and hepatic triglyceride. Total body fat mass was estimated from total body water as measured by the D2O dilution method (18) . D2O enrichments in plasma samples taken from mice 4 h after injection with D2O at a dose of 5 mg per animal as mentioned above were measured using an isotope ratio mass apparatus (DELTA plus XP, Thermo Fisher Scientific, Waltham, MA) equipped with GasBench (Thermo Fisher Scientific). Total body water (Vwater, mL) was calculated from the enrichment (Eplasma, mol%) by the following equation:
Vwater5
Ei3Vi30.98 E plasma31.041 in which, E i and Vi are enrichment and volume of injected D2O solution (i.e. 5% and 100 mL, respectively). Constant values (0.98 and 1.041) are estimated decay factors of D2O enrichments calculated from its half-life (5156 h) in mice and an adjustment factor to convert D2O space to water space (19) , respectively. Assuming that the water content in lean body and fat is 0.732 and 0, respectively (20) , lean body mass (WLBM, g) and total fat mass (Wfat, g) were estimated as
Hepatic triglyceride (TG) in each liver sample (50 mg) was extracted at 80˚C to 1 mL of NP-40 (Nacalai Tesque, Inc., Kyoto, Japan). The supernatants were diluted 100 times for measurements of TG using a Triglyceride Quantification Kit (BioVision, San Francisco, CA).
Blood biochemical analysis. Plasma triglycerides (TG), cholesterol (total, HDL and LDL) and whole blood glucose were quantified enzymatically with an autoanalyzer (Fuji Dry-chem 5500 system, Fujifilm, Tokyo, Japan). Total free fatty acid in the plasma was measured using a Free Fatty Acid Quantification Kit (BioVision). Plasma insulin was measured by ELISA using a mouse insulin assay kit (Morinaga Institute of Biological Science, Yokohama, Japan).
Histological analysis. Formalin-fixed livers and inguinal fat pads were embedded in paraffin, and 4 mm sections were cut and stained with hematoxylin and eosin, according to standard protocols. Inguinal adipocyte sizes were measured using the public domain software ImageJ (Wayne Rasband, National Institute of Health, available at http://rsb.info.nih.gov/ij). Three randomly selected areas in each section were analyzed and mean value was calculated for each animal.
Statistics. All data are presented as means6standard deviations (SD). The statistical significance of the differences between the 2 groups was analyzed by Student's t-test using Prism ver. 5.04 (GraphPad Software, La Jolla, CA). The statistical significance of the differences in pregnancy rate between the 2 groups was analyzed by the Chi-square test using Prism ver. 5.04. A p value of less than 0.05 was considered to indicate statistical significance.
ReSuLTS

Body weight, pregnancy rate and litter size of the first generation
Mice fed standard or HFCS diets were given drinking water with or without 0.064% MSG. As shown in Table  1 , MSG addition to the drinking water did not affect the body weight of the first generation in either sex regard-less of the diets (i.e. standard or HFCS diets). MSG ingestion did not affect the pregnancy rate in either dietary group. There were no statistical differences in numbers of pups or gender ratios of the litters between control and MSG in either dietary group.
Body weight, food intake, water consumption and abdominal girth of the second generation
There were no effects of MSG ingestion on body weight, food intake or water consumption of the second generation at 6 wk or 32 wk old in either dietary group (Table 2) . MSG ingestion did not affect girth size, either. Body weight gain and the ratio of girth size in mice given MSG did not differ from those parameters measured in control mice in either dietary group. Body weights of the first generation were measured 3 wk after the start of the experimental diets and MSG administration. 1 The parenthesis indicates number of pregnant mice/total number mated. Values are means6SD (n520). Significant differences were not observed between control and MSG (Student's t-test, Chi-square test). Initial body weight and girth were measured at 6 wk old and final ones at 32 wk old. Food and water intakes were measured at 28-30 wk of age. Values are means6SD (n520). No statistical differences were seen between control and MSG (Student's t-test). Lean body mass and fat mass of the second generation were measured at 32 wk old using D2O as described in "Materials and Methods." Values are means6SD (n520). No statistical differences were seen between control and MSG (Student's t-test).
Body composition, fat content and blood biochemistry at 32 wk of the second generation MSG administration did not affect lean body mass (g) or whole body fat mass (g and%) measured by D2O dilution method regardless of the diets given (Table 3 ). There were no statistically significant changes caused by MSG administration in weights of epididymal, perirenal or mesenteric fat pads, either. There were no effects of MSG ingestion on hepatic TG content. The results of blood biochemistry are summarized in Table 4 . MSG ingestion did not affect concentrations of TG, free fatty acid, or total cholesterol in the plasma. Plasma concentrations of leptin and adiponectin, hormones released from adipose tissues, were not affected by addition of MSG to the drinking water in either dietary group. MSG ingestion did not affect blood glucose, plasma insulin and HOMA-IR, indices for insulin resistance in mice fed the standard diet. Although blood glucose and plasma insulin in mice given MSG were slightly but statistically significantly lower than those of control in mice fed the HFCS diet, there was no difference in HOMA-IR.
Histological examination of the liver and epididymal fat pad
No apparent effects of MSG ingestion were seen in histological examination of the liver or inguinal fat pad in either dietary group (Figs. 1 and 2 ). There were no effects of MSG ingestion on adipocyte size in inguinal fat pad in mice fed the standard and HFCS diets ( Table 5 ).
DIScuSSION
The present study investigated the effects of MSG given in drinking water to two generations of mice to mimic the study of Collison et al. (13) . Although the original authors reported that MSG administration caused abdominal obesity, insulin resistance and dyslipidemia, the present data were negative and could not reproduce the initial results (13) .
Mainly, no increase in abdominal girth (a marker of visceral adiposity) and no enlargement of adipocyte size were found following MSG administration. Furthermore, no effects of MSG administration on body weight or abdominal (epididymal, mesenteric or perirenal) fat pad weight were seen. The latter finding was confirmed by measuring body composition using D2O. Histological examinations of inguinal fat pads confirmed the absence of differences between control treatment and MSG. These are consistent also with data showing no effect of MSG on plasma leptin, one of the indicators for body fat mass (21) .
Although the reasons for the differences between our results and those originally reported (13) are unclear, the current data indicate that MSG ingestion does not induce fat accumulation. Strong correlation of visceral fat weights (total of epididymal, mesenteric and perirenal fat pads) with fat masses measured using D2O (r50.73 and 0.81 in normal and HFCS dietary groups, respectively) and with leptin concentrations (r50.92 and 0.82 in normal and HFCS dietary groups, respectively) and their mild but significant correlation with girth size (r50.64 and 0.61 in normal and HFCS dietary groups, respectively) and with body weight (r50.52 and 0.62 in normal and HFCS dietary groups, respectively) further point to the reliability of our measurements. There were no effects of MSG administration on any of the variables for adiposity in mice fed the HFCS diet.
The present study also refuted the involvement of MSG in hepatic steatosis, dyslipidemia and insulin resistance. No effects of MSG on hepatic triglyceride content, liver weight or histology were seen in mice fed a normal or a HFCS diet, indicating no involvement of MSG in the generation of hepatic steatosis. This is consistent with data showing no effects of MSG on plasma concentrations of TG, fatty acids or cholesterol in mice. MSG administration did not change blood glucose, plasma insulin concentrations or hence HOMA-IR, an index for insulin resistance, in mice fed the normal diet. In mice fed the HFCS diet, MSG administration lowered blood glucose and plasma insulin concentrations slightly and tended to lower HOMA-IR, but did not increase these parameters for insulin resistance. Thus, no trend to insulin resistance in mice fed MSG was observed, which 
is consistent with the finding that MSG did not affect plasma adiponectin concentrations, which is known to be related to the development of insulin resistance in obesity (22) . The timing of blood collection in the original report (13) and this study might be one of the causes for discrepancy. We collected blood samples from mice starved for 6 h for glucose and insulin measurements, since this protocol is reportedly suitable to assess insulin resistance compared to an overnight starvation protocol (23, 24 (23), indicating potential technical problems in their study. It is known that direct exposure of glutamatergic neurons to large doses of glutamate and/or MSG causes cell death due to excitotoxicity (25) and that large doses of MSG directly injected into newborn mice cause neuronal cell death in the hypothalamus and neural obesity (26) . However, those in vitro studies or studies using just-born mice injected intravenously or intraperitonealy have no impact on the use of food ingredients. Yet, based on exactly those interventions, Collison et al. discussed their initial findings, linked them to hypothalamic obesity and ignored the published literature on food-added glutamates (7) (8) (9) . Briefly, most of the glutamate ingested orally is metabolized in the first pass, i.e., in the gut; therefore metabolism of MSG and/or glutamate is different depending on the route of administration. Indeed there are many studies indicating no neural toxicity by oral administration of MSG even when higher doses than in the present study were given (14, 27, 28) .
The present authors used a dose of MSG which was too low to anticipate any adverse effect when the present knowledge of MSG metabolism is considered (7) (8) (9) . In this study, daily MSG intake was estimated as low as 0.1 g/kg BW/d (note, not bolus but daily), while as much as 3 g/kg BW of MSG was administered by a single injection (note, not orally) to newborn mice to cause neural toxicity (26) . Further it should be noted that intake of glutamate from drinking water was very small compared to the intake from the diet used in the present study, and presumably also in Collison's study. The former was estimated as low as 0.09 g/kg/d, while the lat-ter was approximately 7.3 and 4.4 g/kg/d, in the control and the HFCS diet, respectively. Thus, it is hardly possible that such a low dose of MSG ingestion in the present or Collison's study affected the central nervous system (14, 15, (27) (28) (29) (30) . Regarding sodium, its intake from drinking water in the present study was estimated to be as low as 0.01 g/kg/d, which was much lower than the NOAEL of sodium in mice (31) . Sodium intake from drinking water was also much lower than dietary intakes (0.67 and 0.40 g/kg/d in normal and HFCS dietary groups, respectively). The present results indicate MSG administration did not cause any adverse effects related to obesity, which is consistent with the general knowledge about the metabolism and safety of food-added glutamate and sodium (5, 7-9, 12, 14, 15) . In support of this notion, Rezaei et al. (32) recently reported that supplementing up to 4% MSG to the diet for young pigs for 3 wk was safe, had no effect on hepatic histology, and beneficially reduced concentrations of total lipids in liver and skeletal muscle.
In conclusion, the present two-generation mice study found no impact of MSG ingestion on growth, body composition, fat accumulation, or blood biochemical indices for insulin resistance or fat metabolism. Size of each adipocyte area was measured by image analysis as described in "Materials and Methods" in 3 randomly selected fields of each inguinal fat pad section. Mean and SD values for 8 mice selected randomly in each group were calculated from average adipocyte size of individual mice. No statistical differences were seen between control and MSG in either dietary group (Student's t-test).
